Ignite Creation Date:
2024-05-06 @ 10:33 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03280563
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2017-09-11
Brief Title:
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor HR-Positive Human Epidermal Growth Factor Receptor 2 HER2-Negative Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche